Could ETQ's share price be soon to benefit from their developments with the new UVGI Nightingale Mobile Air Filtration Product.

New UVGI air filtration product

In November 2002, the ETQ announced its new Nightingale UVGI air filtration product, to be produced by a new joint-venture company, UVGI Systems Limited, owned 55% by the Group and 45% by Suvair Limited. This rapid response mobile air filtration unit is capable of killing the MRSA super bug and other airborne pathogens.

The UVGI unit has widespread application where there is need to keep
air free of dangerous live bacteria, viruses, and fungal spores, including
hospitals, schools, cruise liners, aircraft, food processing, and military
applications.

The UVGI unit uses a high intensity Ultra Violet Germicidal Irradiation ('UVGI')
filter, which has been designed to control harmful and dangerous airborne
pathogens, such as Anthrax, Tuberculosis, and Staphylococcus aureus, the
causative agent in MRSA. The filtration system is combined with use of high
intensity Ultra Violet light, which inactivates micro organisms by disrupting
their DNA structure.

Tests of a prototype at the Defence Science Technology Laboratory ('Dstl') at
Porton Down, the centre for excellence for the Ministry of Defence, showed that
the UVGI unit captured and/or destroyed more than 99.9% of Bacillus subtilis
spores, a simulant for Anthrax bacteria.

Since November, second generation units have been developed, which will go on
applications testing at an NHS Trust Hospital in December 2003, following
building completion of its new haematology unit. It is also anticipated the
UVGI unit will shortly go on laboratory testing in the United States with
contractors nominated by the Department of Homeland Security.

Concern seems to be hotting up on the T.V. news that the MRSA super bug is still killing and disabling people visiting or as patients in NH Trust hospitals. It would be surprising if NH Trust hospital do not notice and Buy this product before they get to many expensive law suits for compensation claims.

Definitely a stock that could soon be heading north. Worth buying in but DYOR

L.

RELATED NEWS LINKS

Sky News Sun 28th Sept 03 - NEW ANTIBIOTICS WARNING
BBC World News Thurs 4th December 03 - Hospital infections: Case studies
BBC World News Fri 5th Dec 03 - 'Superbug' crackdown is launched
BBC World News Monday 22nd Dec 03 - Superbugs lurk in intensive care
Sky News Sun 14th Dec 03 - SUPERBUG CARRIED BY PETS
BBC World News Thurs 26th Feb 04 - Superbug deaths increase 15-fold
BBC World News Mon 22nd March 04 - MRSA superbug hits more children
BBC World News Fri 2nd April 04 - Superbug outbreak in cardiac ward
BBC World News Thurs 8th April 04 - NHS faces superbug legal claims
BBC World News Sun 6th June 04 - Government 'complacent' over MRSA
BBC World News Fri 18th June 04 - Superbug deaths 'set to double'
BBC World News Thurs 1st July 04 - Holland's tough line combats MRSA
BBC World News Thurs 1st July 04 - Overcrowded hospitals breed MRSA
ITV.com Fri 9th July 04 - Mother's MRSA nightmare
ITV.com Fri 9th July 04 - 'MRSA superbug has done this to me'
ITV.com Fri 9th July 04 - Precautions you can take against MRSA
Sky News Sun 11th July 04 - WAR DECLARED ON MRSA
BBC UK News Mon 12th July 04 - Drive to fight hospital superbugs

Sue cannot see what choice the NHS have. Here is a product that can help in the fight against MRSA .When Hospitals in the US are all ready starting to take up the product. If the NHS fail to support Nightingale and MRSA continues to kill, they ( NHS ) will find themselves with a PR nightmare, when the general public discover what is going on.

what is the price expectancy on this for 2004

just how many cases of superbug have been contracted from air , not many I would think , most cases from dirty hands , dirty everything else , HCEG has got more going for it.

Agree Mad doc also hold HCEG. Good threads on MW website.But a combination of both approaches will imho eradicate MRSA.At present though ETQ has the momentum behind it and is a 1/6th of the value of HCEG.

True MRSA is a contact bug, but the case for having an isolation ward for infected patients is a must and that environment should be kept as sanitised as is poss. Times are moving forward and I'm sure a few years from now people will think it their right to have clean air, especially inside a hospital and in the workplace. A machine such as this that kills 99% of all airbourne germs dead (just as domestos does the loo) has wider implications / benifits for any purchaser. An outbreak of SARS for example could be controlled more easily with proper facilities like isolation wards.

Yoyo , I agree with your argument but the other 1% can still get you !

Press mention : will appear in tomorrow's Daily Mail Newspaper.

Beyond the Footsie: Friday close
6 August 2004, This Is Money

Hopes of a deal with the NHS saw Energy Technique rally 1.13p to 7p. The company is behind the Nightingale air filtration unit that kills the MRSA hospital superbug, and will address a health commission looking into the superbug crisis.

http://www.thisismoney.com/20040806/nm81192.html

Investtech Analysis after today's close :

Weak Positive Candidate (Short term) - Aug 6, 2004
ENERGY TECH. ORD 1P has broken the falling trend and reacted strongly up. For the time being, it is difficult to say anything about the future trend direction. The stock has support at p 5.10 and resistance at p 8.10. Volume tops and volume bottoms correspond well with tops and bottoms in the price. Volume balance is also positive, which strengthens the stock. The stock is overall assessed as technically slightly positive for the short term.

Neutral (Medium term) - Aug 6, 2004
Is within a falling trend, which indicates a continued decline. Has, however, received a positive signal from the moving average indicator, thus signaling a continued rise. The stock has support at p 3.50 and resistance at p 11.20. The volume balance is positive and strengthens the stock in the short term. The stock is overall assessed as technically neutral for the medium long term.

Weak Positive Candidate (Long term) - Aug 6, 2004
Is within a falling trend, which indicates a continued decline. Has met the objective at 12.66 after a break of a inverse head and shoulders formation. The price has now fallen, but the formation indicates further rise. The stock has support at p 3.50 and resistance at p 11.20. Volume tops correspond well with price tops, and volume bottoms correspond well with price bottoms. Volume balance is also positive, which weakens the falling trend and could be an early signal for a coming trend break. Trading volume has increased substantially lately, which may be because of fundamental news. The stock is overall assessed as technically slightly positive for the long term.

Best - Charts update at close :

5 Buy Signals
0 Sell Signals

15 Bullish Indicators
1 Bearish Indicator

The bearish indicator is MACD which will do the crossover & go bullish on the next tick up though the MACD indicator on the MONEY AM MACD indicator has already gone bullish today. The line for today has appeared above the horizontal line (see below).

maddoc, yes an interesting statistic:- 1:1 people die!

http://www.moneyam.com/InvestorsRoom/ShowPostList?fID=1&tID=3592

Approximately 178,000 shares buy has gone through at a premium to the indicative offer price at a price of 7.375 pence. Interesting.

The 178,000 odd buy orginally went through at 8.13 this morning and reported 1 hour later. Trades over 150,000 shares are delayed in reporting by 1 hour.

With L2 at 1 v 2, a shake may be coming on the bid. One just has to remind themselves of all the heavy buying from roughly the open on Friday at 7.00-7.50 pence. And the 180K odd buy today at a premium price of 7.375 pence.

As always the market makers like playing with the bid price, keep an eye on the offer price.

sh do you know when the talks start with nhs,tried to speak with company this morning,poor communication was passed from one person to another without answer.cheers woodie

my broker is offering ETQ at 6.875

Woodie,

I think some discussions are underway already, these would certainly happen in parallel with trials.

The Health Commission that was mentioned in the RNS was September 1st meeting at Newton Aycliffe, County Durham. The Newton Aycliffe forum has been organised by the Commission for Patient and Public Involvement in Health, an independent public body sponsored by the Department of Health. Its forums - run independently of the DoH, are intended to bring local needs into policy making agendas.


Energy Technique Managing Director Leigh Stimpson said: "This marks a welcome advance in our efforts to make contact with influential opinion formers and decision makers within the NHS."

Mr Stimpson added: "We are especially pleased to be able to talk to members of
the public - the growing threat of MRSA in our hospitals is an issue that
affects everybody."

-------------------------

What will be important for energy tecnique is public knowledge and opinion..we all are aware how public pressure can often drive decisions ( positively or negatively) and this may force the hand, so to speak, of the NHS and other health bodies. I am sure that there maybe even more pressure from private patients towards BUPA and the like.

GN

gn thanks for reply.cheers woodie

Hi Woodie, I think the main meeting point in on the 1st of September (see below) :

The company will tell NHS chiefs and members of the public how Nightingale has
been shown to be 99.8% effective by the Health Protection Agency at Porton Down,
Wiltshire.

The invitation to address the September 1st meeting at Newton Aycliffe, County
Durham, comes as Energy Technique continues discussions to sell Nightingale
units into the National Health Service.

Energy Technique Managing Director Leigh Stimpson said: "This marks a welcome
advance in our efforts to make contact with influential opinion formers and
decision makers within the NHS."

WINS have moved up on the bid as reflected with the tick up on the bid to 6.50 pence on barely any buys. Well the bid price did tick down on barely any sells as well. As I say they do keep moving the bid price around, as always with this stock you get a better indication with what the offer price is at.

Level 2 : 1 v 3

whats the price expectancy on this short term

MMs really teasing us with the bid price today, bought another 62,902 shares at 6.94 pence just now (3rd batch, first at 4.95 pence, then at 6.55 pence and now at 6.94 pence). Buys outweigh Sells today with barely any sells of any significance.